|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.73 USD | -0.86% |
|
+9.54% | +161.99% |
| 06-29 | Roche takes aim at Illumina's dominance with new gene sequencing machine | RE |
| 06-29 | Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip | RE |
| Market Cap | 5.42B 4.75B 4.38B 4.04B 7.67B 517B 7.8B 52.29B 20.54B 255B 20.37B 19.93B 876B | P/E 2026 * |
-52.4x | P/E 2027 * | -59.6x |
|---|---|---|---|---|---|
| Enterprise Value | 4.94B 4.32B 3.99B 3.68B 6.99B 471B 7.1B 47.62B 18.7B 232B 18.55B 18.15B 798B | EV / Sales 2026 * |
8.05x | EV / Sales 2027 * | 7.32x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 10x Genomics, Inc.
| 1 day | -0.86% | ||
| 1 week | +9.54% | ||
| Current month | +11.45% | ||
| 1 month | +48.16% | ||
| 3 months | +83.63% | ||
| 6 months | +115.81% | ||
| Current year | +161.99% |
| 1 week | 35.12 |  | 43.23 |
| 1 month | 29.66 | | 43.23 |
| Current year | 15.9 | | 43.23 |
| 1 year | 11.16 | | 43.23 |
| 3 years | 6.78 | | 63.57 |
| 5 years | 6.78 | | 191.15 |
| 10 years | 6.78 | | 208.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Serge Saxonov
CEO | Chief Executive Officer | 49 | 2012-07-01 |
Ben Hindson
PSD | President | 51 | 2012-09-30 |
Adam Taich
DFI | Director of Finance/CFO | 51 | 2024-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Hindson
BRD | Director/Board Member | 51 | 2012-07-01 |
Serge Saxonov
BRD | Director/Board Member | 49 | 2012-07-01 |
John Stuelpnagel
CHM | Chairman | 68 | 2013-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Sell | Founder | -30,000 | 0.0257% | ||
| 06-15 | Sell | Director | -5,723 | 0.0049% | ||
| 06-03 | Free | Director | 8,829 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | +9.54% | +233.83% | -28.23% | 5.42B | |
| -2.46% | -4.72% | +218.51% | +323.86% | 21.22B | |
| -2.58% | +0.14% | -41.49% | -25.12% | 9.41B | |
| -0.33% | -3.87% | +29.92% | +25.91% | 6.88B | |
| +3.74% | -1.63% | -21.04% | -27.79% | 5.05B | |
| -4.92% | -7.16% | -35.91% | - | 4.8B | |
| 0.00% | -1.40% | -24.07% | -27.53% | 4.17B | |
| +0.75% | -11.50% | +60.48% | +70.78% | 3.64B | |
| +0.62% | -0.77% | -18.68% | -43.38% | 2.59B | |
| +3.72% | +1.08% | -33.53% | +200.90% | 1.61B | |
| Average | -0.23% | -1.73% | +36.80% | +52.16% | 6.48B | |
| Weighted average by Cap. | -1.20% | -1.90% | +84.24% | +114.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 614M 537M 495M 457M 868M 58.56B 883M 5.92B 2.32B 28.85B 2.31B 2.26B 99.17B | 670M 586M 540M 499M 947M 63.88B 963M 6.46B 2.54B 31.47B 2.52B 2.46B 108B |
| Net income | -105M -91.78M -84.65M -78.19M -148M -10.01B -151M -1.01B -397M -4.93B -394M -385M -16.95B | -93.32M -81.62M -75.29M -69.53M -132M -8.9B -134M -900M -353M -4.38B -350M -343M -15.07B |
| Net Debt | -485M -424M -391M -361M -685M -46.22B -697M -4.67B -1.83B -22.77B -1.82B -1.78B -78.28B | -524M -459M -423M -391M -741M -50B -754M -5.05B -1.98B -24.63B -1.97B -1.93B -84.67B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$42.73 | -0.86% | 2,832,915 |
| 26-07-09 | US$43.10 | +15.03% | 2,997,474 |
| 26-07-08 | US$37.47 | -0.95% | 3,100,234 |
| 26-07-07 | US$37.83 | -5.43% | 2,432,456 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TXG Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
